scholarly article | Q13442814 |
P50 | author | Inmaculada Casas | Q41274828 |
Amparo Larrauri | Q41928148 | ||
F Pozo | Q55069602 | ||
Silvia Jiménez-Jorge | Q56486868 | ||
P2093 | author name string | Spanish Influenza Sentinel Surveillance System | |
cycEVA Study Team | |||
S de Mateo | |||
C Savulescu | |||
J Ledesma | |||
P2860 | cites work | Estimates of pandemic influenza vaccine effectiveness in Europe, 2009-2010: results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) multicentre case-control study | Q21144621 |
Early pandemic influenza (2009 H1N1) in Ho Chi Minh City, Vietnam: a clinical virological and epidemiological analysis | Q28473959 | ||
Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada. | Q30357784 | ||
Estimating influenza vaccine effectiveness using routinely collected laboratory data. | Q30382480 | ||
Protective effect of single-dose adjuvanted pandemic influenza vaccine in children | Q30391363 | ||
Effectiveness of seasonal 2008–2009, 2009–2010 and pandemic vaccines, to prevent influenza hospitalizations during the autumn 2009 influenza pandemic wave in Castellón, Spain. A test-negative, hospital-based, case–control study | Q30394200 | ||
Effectiveness of the 2010/11 seasonal trivalent influenza vaccine in Spain: preliminary results of a case-control study | Q30401132 | ||
Antibody persistence and response to 2010-2011 trivalent influenza vaccine one year after a single dose of 2009 AS03-adjuvanted pandemic H1N1 vaccine in children | Q30409092 | ||
Vaccine effectiveness in preventing influenza hospitalizations in Navarre, Spain, 2010-2011: cohort and case-control study | Q30409727 | ||
Using surveillance data to estimate pandemic vaccine effectiveness against laboratory confirmed influenza A(H1N1)2009 infection: two case-control studies, Spain, season 2009-2010. | Q30410112 | ||
Estimation of type- and subtype-specific influenza vaccine effectiveness in Victoria, Australia using a test negative case control method, 2007-2008 | Q33931144 | ||
Evidence of bias in estimates of influenza vaccine effectiveness in seniors | Q34478438 | ||
Confounding by indication in non-experimental evaluation of vaccine effectiveness: the example of prevention of influenza complications | Q35013711 | ||
Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines | Q37039271 | ||
Assessing vaccine efficacy in the field. Further observations | Q39560755 | ||
Evaluating vaccination effectiveness and vaccine efficacy by means of case-control studies | Q40632458 | ||
Influenza vaccine effectiveness in preventing hospitalization for pneumonia in the elderly | Q43418868 | ||
Estimating the influenza vaccine effectiveness in elderly on a yearly basis using the Spanish influenza surveillance network--pilot case-control studies using different control groups, 2008-2009 season, Spain | Q45792636 | ||
Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season | Q46159620 | ||
Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. | Q50801938 | ||
Evidence of bias in studies of influenza vaccine effectiveness in elderly patients. | Q53062872 | ||
Effectiveness of H1N1/09 monovalent and trivalent influenza vaccines against hospitalization with laboratory-confirmed H1N1/09 influenza in Australia: A test-negative case control study | Q57210380 | ||
P433 | issue | 24 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | vaccine | Q134808 |
influenza vaccine | Q383260 | ||
P304 | page(s) | 3595-3602 | |
P577 | publication date | 2012-03-31 | |
P1433 | published in | Vaccine | Q7907941 |
P1476 | title | Effectiveness of the 2010-11 seasonal trivalent influenza vaccine in Spain: cycEVA study | |
P478 | volume | 30 |
Q30417900 | Age-specific vaccine effectiveness of seasonal 2010/2011 and pandemic influenza A(H1N1) 2009 vaccines in preventing influenza in the United Kingdom |
Q35211657 | Application of the screening method to monitor influenza vaccine effectiveness among the elderly in Germany |
Q47613621 | Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015-2016 Season in Canada |
Q39530697 | Case-Control Study of Vaccine Effectiveness in Preventing Laboratory-Confirmed Influenza Hospitalizations in Older Adults, United States, 2010-2011. |
Q38819920 | Concordance of interim and final estimates of influenza vaccine effectiveness: a systematic review |
Q37331059 | Contribution of influenza viruses to medically attended acute respiratory illnesses in children in high-income countries: a meta-analysis |
Q53283393 | Does consecutive influenza vaccination reduce protection against influenza: A systematic review and meta-analysis. |
Q30401497 | Effect of Repeated Vaccination With the Same Vaccine Component Against 2009 Pandemic Influenza A(H1N1) Virus |
Q30403059 | Effect of previous and current vaccination against influenza A(H1N1)pdm09, A(H3N2), and B during the post-pandemic period 2010-2016 in Spain |
Q34033876 | Effectiveness of 2012-2013 influenza vaccine against influenza-like illness in general population: estimation in a French web-based cohort |
Q34993133 | Effectiveness of influenza vaccine against laboratory-confirmed influenza, in the late 2011-2012 season in Spain, among population targeted for vaccination |
Q30367263 | Effectiveness of pandemic and seasonal influenza vaccines in preventing laboratory-confirmed influenza in adults: a clinical cohort study during epidemic seasons 2009-2010 and 2010-2011 in Finland. |
Q34451202 | Effectiveness of seasonal influenza vaccine in community-dwelling elderly people: a meta-analysis of test-negative design case-control studies |
Q92942088 | Effectiveness of the current and prior influenza vaccinations in Northern Spain, 2018-2019 |
Q46200283 | Effectiveness of trivalent and monovalent influenza vaccines against laboratory-confirmed influenza infection in persons with medically attended influenza-like illness in Bavaria, Germany, 2010/2011 season |
Q51174772 | Estimates of influenza vaccine effectiveness in primary care in Scotland vary with clinical or laboratory endpoint and method--experience across the 2010/11 season. |
Q91576267 | Evaluating the impact of the weather conditions on the influenza propagation |
Q36222025 | Factors associated with staff and physician influenza immunization at a children's hospital in Ontario, Canada |
Q34786909 | Field seasonal influenza vaccine effectiveness: evaluation of the screening method using different sources of data during the 2010/2011 French influenza season |
Q30833500 | Higher vaccine effectiveness in seasons with predominant circulation of seasonal influenza A(H1N1) than in A(H3N2) seasons: test-negative case-control studies using surveillance data, Spain, 2003-2011. |
Q56791503 | Influenza Vaccine Effectiveness in Preventing Outpatient, Inpatient, and Severe Cases of Laboratory-Confirmed Influenza |
Q41612054 | Influenza vaccine effectiveness estimates in Croatia in 2010-2011: a season with predominant circulation of A(H1N1)pdm09 influenza virus |
Q42237299 | Interim estimates of 2013/14 vaccine effectiveness against influenza A(H1N1)pdm09 from Canada s sentinel surveillance network, January 2014. |
Q42148972 | Interim influenza vaccine effectiveness: A good proxy for final estimates in Spain in the seasons 2010-2014. |
Q44243917 | Moderate influenza vaccine effectiveness with variable effectiveness by match between circulating and vaccine strains in Australian adults aged 20-64 years, 2007-2011. |
Q34778408 | Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic review |
Q39340731 | Repeated annual influenza vaccination and vaccine effectiveness: review of evidence |
Q90692852 | The Use of Test-negative Controls to Monitor Vaccine Effectiveness: A Systematic Review of Methodology |
Q37260000 | The case test-negative design for studies of the effectiveness of influenza vaccine in inpatient settings |
Q51225150 | The case test-negative design for studies of the effectiveness of influenza vaccine. |
Q38639994 | The impact of repeated vaccination on influenza vaccine effectiveness: a systematic review and meta-analysis |
Q60912426 | The impact of repeated vaccination on influenza vaccine effectiveness: a systematic review and meta-analysis |
Q38803189 | Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies |
Q39884379 | Waning protection of influenza vaccine against mild laboratory confirmed influenza A(H3N2) and B in Spain, season 2014-15. |
Search more.